Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder - Wikidata - awgldk - TriplyDB

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

http://www.wikidata.org/entity/Q37250508

about

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System Serotonin-norepinephrine reuptake inhibitors may exacerbate stiff-person syndrome Autoimmune Movement Disorders: a Clinical and Laboratory Approach.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Understanding anti-IgLON5 disease.Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.DPPX antibody-associated encephalitis: Main syndrome and antibody effects.A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome.Acute Respiratory Failure in a Patient with Stiff-Person Syndrome.Treatment strategies for autoimmune encephalitis.Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.[Paraneoplastic neurological syndromes : A current summary].Pruritus in anti-DPPX encephalitis.The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders Pragmatic Treatment of Stiff Person Spectrum Disorders A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon Inpatient care for stiff person syndrome in the United States: a nationwide readmission study

P2860

Q26746048-5714D773-7401-469C-A125-F744A827F81E Q37216577-275FB31F-46E9-4BFE-A457-8FBC9224446A Q39102143-86A595EE-2DA4-4FC2-890D-C75A617690AC Q39180685-842A3B75-202A-4A62-8F35-87684B5B6E51 Q42349934-98717D07-400C-4AA1-8A8D-68DCADB2DC30 Q47623969-4F45D75E-E295-418C-9DEB-DD8339378C5F Q47786064-7106F463-6DDA-4668-AB29-6F6B918064FA Q48021708-9F4A66D8-2376-444F-81FA-27891480351F Q48154570-051489D4-CE8E-44AE-BC02-82F1F83A9CCF Q49213573-B37099D3-8D3A-46A9-8685-32502FA8CEFB Q49724191-0BAFD807-2A2F-4FC4-BC73-2B3F7547CC99 Q50073398-8A192405-54BD-48D6-A133-778E977BF9AC Q55114040-82077D90-348A-4FB6-A93C-9F7AA2522D74 Q57157350-74D7B8F8-5E99-46E9-AC3F-C60185D72F2E Q58568103-FB26ADC9-522D-4E6D-9EE2-3AFBDEBDC156 Q58593273-28C73E8C-792D-4505-941D-A15FB2ECC648 Q58798881-4512F2CD-B641-4B06-9C41-3829B1D1A9CE

P2860

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

http://www.wikidata.org/entity/Q37250508

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

@en

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

@nl

type

label

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

@en

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

@nl

prefLabel

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

@en

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

@nl

P1433

Q37250508-C0E6EF50-7822-4F5D-B1C3-A43BEB4F71F7

P1476

Q37250508-6B2AE109-A256-4030-9B93-A8B115DB05A9

P2093

Q37250508-11647CF0-80D8-4435-A578-C4D3F117447F

Q37250508-2088FF6B-C7B8-4D41-A0F9-CA3F28CCD6D1

Q37250508-4058F556-C9F8-413A-A11D-42A42877B70A

Q37250508-7D1490A3-DF95-491C-A03C-C202A2A8DC9C

Q37250508-8904ECFE-81AC-43B0-A358-7BE7EC08F86A

Q37250508-94F47D5F-C388-4F86-B2B2-F794794547A4

Q37250508-B00F738C-0148-404E-91DB-036F05DB0DB1

P2860

Q37250508-0993B2D6-225C-41FA-BC18-3B2B4600308C

Q37250508-100ED480-8EA1-4704-BFAE-AFCAB9D95A04

Q37250508-19186947-4FA7-49C1-80A4-B72D3AC59FE7

Q37250508-264B1A27-9107-4198-9709-E0F0DB7FF55C

Q37250508-2C334F93-0C59-4633-8F5B-63981850049B

Q37250508-431A2DAD-A7CF-4CE0-8850-2839F7484F45

Q37250508-45D8D709-D837-42E7-AFE8-EB6E22B4126E

Q37250508-5EE7B6B2-D0AF-489C-B146-B67F750EC2D8

Q37250508-5F76B974-7236-4C19-8C24-2E411AAC1C02

Q37250508-658CE270-7F17-425B-AD9C-84C1AD112598

P304

Q37250508-61374BA9-BCD8-4B4B-A605-EDF487B5D3A1

P31

Q37250508-5B68B2BC-CFC6-46BB-A57F-FD0090C5AD9C

P356

Q37250508-421AC53E-E3EC-4017-BA61-95F27CB30C81

P407

Q37250508-0AFA1BA8-8E13-4766-8B26-8EB028DAE092

P433

Q37250508-F7C05833-1D48-4FAA-9644-B562CCE42685

P478

Q37250508-C794AEBB-B2E1-4F40-A1BF-7DEE71BA1475

P50

Q37250508-3BAEF165-B915-4BB2-9976-EE653E17A78F

Q37250508-3FD58074-35D4-4963-8CC0-D305C707382A

Q37250508-615EF0AC-33C4-43F9-B3A9-FAF569D9CC26

Q37250508-6E6E13D6-46C6-4791-8988-4DDF45A0DEFB

Q37250508-90DE922F-0805-4949-81FB-0BDA7417C382

Q37250508-A3C1EE9E-BB26-4C3F-88EA-E56E3C05BC39

Q37250508-FB7F4C7A-6739-4C20-A7FB-D213637E5E98

P577

Q37250508-C58E946A-1B2D-40EF-8900-13F1F3279E0D

P5875

Q37250508-70056067-A2EA-4196-B193-F8C1099B7798

P698

Q37250508-57477D40-0383-46FD-8814-8AFF7E1AA794

P932

Q37250508-33D987CB-8294-47C7-A7C3-9C3D6CD9BE21

P356

JAMANEUROL.2016.0133

P1433

P1476

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder

@en

P2093

Albert Saiz

http://www.w3.org/2001/XMLSchema#string

Eric Lancaster

http://www.w3.org/2001/XMLSchema#string

Jesús Planagumà

http://www.w3.org/2001/XMLSchema#string

Mateus M Simabukuro

http://www.w3.org/2001/XMLSchema#string

Robert J Harvey

http://www.w3.org/2001/XMLSchema#string

Takahiro Iizuka

http://www.w3.org/2001/XMLSchema#string

Yolanda Blanco

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Autoimmunity to gephyrin in Stiff-Man syndrome

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype.

The glycinergic system in human startle disease: a genetic screening approach.

Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

The stiff-person syndrome: an autoimmune disorder affecting neurotransmission of gamma-aminobutyric acid.

The stiff man and stiff man plus syndromes.

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

P304

714-720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMANEUROL.2016.0133

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Mar Petit-Pedrol

Maarten J. Titulaer

Eugenia Martinez-Hernandez

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301216879

http://www.w3.org/2001/XMLSchema#string

P698

27065452

http://www.w3.org/2001/XMLSchema#string

P932

5020136

http://www.w3.org/2001/XMLSchema#string